News
FDA singles out Avicenna Alliance to form part of EU delegation
Next week of 15 May 2017-18 May, the Avicenna Alliance will have a busy week ahead. The FDA has invited the Avicenna Alliance to visit the FDA for high level talks on the future of regulation of in silico medicine will take place on 15 May. The full invitation letter can be found below. Avicenna Alliance welcomes this collaboration with the FDA and looks forward to the next steps towards effective regulation of the in silico market.
Promeditec joins Avicenna Alliance!
Avicenna Alliance is proud to announce the newest addition to its list of members: Promeditec.
EFGCP becomes an institutional member of the Avicenna Alliance!
This month, Avicenna Alliance is delighted to announce that the European Forum For Good Clinical Practice (EFGCP) officially joined the Avicenna Alliance as an institutional member.
Avicenna Alliance member VPH Institute at Europa Forum Lech 2017
Prof. Lies Geris, director of Virtual Physiological Human Institute and Avicenna Alliance Research Member, representing 50% of the Alliance, received a personal invitation to participate to the 6th edition of the "Europa Forum Lech 2017" which this year will take place from 19-21 April 2017.
HMA/EMA will establish a Joint Big Data Task Force
The European Medicines Agency (EMA) along with the heads of national competent authorities in the European Economic Area (EEA), created a new task force to explore how medicines regulators in the EEA can use big data to support research, innovation and robust medicines development to benefit human health.
Avicenna Alliance’s Secretary General to give keynote speech at ICCAI 2017
On 27-29 July 2017, the Society for Complex Acute Illness (SCAI) will organise the 16th annual International Conference on Complex Acute Illness (ICCAI) in Milan, Italy during which Avicenna Alliance’s Secretary General, Dr. Adriano Henney will deliver a keynote speech.
